[PDF][PDF] Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children

…, NN Brodsky, TS Sumida, M Comi, H Asashima… - Immunity, 2021 - cell.com
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious
complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV-2 infection…

Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19

…, AY Zhao, V Gasque, JC Schupp, H Asashima… - Nature …, 2022 - nature.com
Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe
COVID-19. However, the immune signatures associated with immunopathology are poorly …

High-plex protein and whole transcriptome co-mapping at cellular resolution with spatial CITE-seq

Y Liu, M DiStasio, G Su, H Asashima, A Enninful… - Nature …, 2023 - nature.com
In this study, we extended co-indexing of transcriptomes and epitopes (CITE) to the spatial
dimension and demonstrated high-plex protein and whole transcriptome co-mapping. We …

[HTML][HTML] Cutting edge: distinct B cell repertoires characterize patients with mild and severe COVID-19

…, A Unterman, TS Sumida, H Asashima… - The Journal of …, 2021 - journals.aai.org
Protective immunity against COVID-19 likely depends on the production of SARS-CoV-2–specific
plasma cells and memory B cells postinfection or postvaccination. Previous work has …

Impaired TIGIT expression on B cells drives circulating follicular helper T cell expansion in multiple sclerosis

H Asashima, PP Axisa, THG Pham… - The Journal of …, 2022 - Am Soc Clin Investig
B cell depletion in patients with relapsing-remitting multiple sclerosis (RRMS) markedly prevents
new MRI-detected lesions and disease activity, suggesting the hypothesis that altered B …

[PDF][PDF] Multi-omic longitudinal study reveals immune correlates of clinical course among hospitalized COVID-19 patients

…, ML Anderson, EJ Anderson, A Arnett, H Asashima… - Cell Reports …, 2023 - cell.com
The IMPACC cohort, composed of >1,000 hospitalized COVID-19 participants, contains five
illness trajectory groups (TGs) during acute infection (first 28 days), ranging from milder (TG1…

Clinical practice guideline for Sjögren's syndrome 2017

…, M Moriyama, H Takahashi, H Asashima… - Modern …, 2018 - academic.oup.com
Objectives: The objective of this study is to develop clinical practice guideline (CPG) for
Sjögren’s syndrome (SS) based on recently available clinical and therapeutic evidences. …

Primary and secondary surveys on epidemiology of Sjögren's syndrome in Japan

H Tsuboi, H Asashima, C Takai, S Hagiwara… - Modern …, 2014 - academic.oup.com
Objective. To characterize the epidemiology of Sjögren's syndrome (SS), including prevalence,
disease type, extra-glandular involvement, satisfaction of diagnostic criteria sets, and …

[PDF][PDF] PD-1highCXCR5–CD4+ peripheral helper T cells promote CXCR3+ plasmablasts in human acute viral infection

H Asashima, S Mohanty, M Comi, WE Ruff, KB Hoehn… - Cell Reports, 2023 - cell.com
T cell-B cell interaction is the key immune response to protect the host from severe viral infection.
However, how T cells support B cells to exert protective humoral immunity in humans is …

Effect of biological disease-modifying anti-rheumatic drugs on airway and interstitial lung disease in patients with rheumatoid arthritis

…, H Takahashi, S Hagiwara, H Asashima… - Internal …, 2019 - jstage.jst.go.jp
Objective Biological disease-modifying anti-rheumatic drugs (bDMARDs) represent an
important advance in alleviating rheumatoid arthritis (RA), but their effect on rheumatic airway …